Shocking! Lawyer rams Mercedes car into Kachori shop in Delhi, Six injured In a shocking incident, six people were injured ...

After multiple rejections, Lexicon Pharmaceuticals is inching toward an FDA decision date next month for its adjunct type 1 ...

Q3 2024 Earnings Call Transcript November 6, 2024 Tandem Diabetes Care, Inc. beats earnings expectations. Reported EPS is $-0 ...

Announced Exclusive Licensing Agreement with Viatris for Sotagliflozin in all Markets Outside of the U.S. and EuropeCompleted ZYNQUISTA™ FDA ...

We are living in exciting times regarding therapies for people with diabetes. Much of the excitement ... precise regulatory guidance will still be needed for discussion and decision making about ...

Diabetes is a global health concern, with a significant impact on heart health. The condition damages blood vessels and ...

Lexicon Pharmaceuticals received a negative vote from a Food and Drug Administration advisory committee for Zynquista as an adjunct to insulin therapy for glycemic control in adults with Type 1 ...

Lexicon Pharmaceuticals shares have been halted all day as a Food and Drug Administration advisory committee was scheduled to vote on Zynquista as an adjunct to insulin therapy for glycemic control in ...

It was the first time he had told his employer that he had diabetes and he had never requested accommodation ... a clear ...

The world once again will spend time talking about Diabetes on World Diabetes Day (November 14th). As we all encourage each other to get tested ...